A review of analytical methods for eicosanoids in brain tissue

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 964, Issue , 2014, Pages 50-64

  Puppolo, Michael ^a   Varma, Deepti ^a   Jansen, Susan A ^a  

^a Temple University   (United States)

Author keywords

Brain tissue; Eicosanoids; Gas chromatography mass spectrometry; High pressure liquid chromatography mass spectrometry; Tandem mass spectrometry; Ultra high pressure liquid chromatography mass spectrometry

Indexed keywords

BRAIN; DISEASES; GAS CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PATHOLOGY;

BRAIN TISSUE; EICOSANOIDS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HIGH-PRESSURE LIQUID; TANDEM MASS SPECTROMETRY; ULTRAHIGH PRESSURE;

TISSUE ENGINEERING;

ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 3; CYTOCHROME P450; DIHYDROXYICOSATETRAENOIC ACID; EPOXYICOSATRIENOIC ACID; HYDROXYICOSATETRAENOIC ACID; ICOSANOID; LIPOXYGENASE; PROSTAGLANDIN; UNCLASSIFIED DRUG; ARACHIDONIC ACID DERIVATIVE;

ANALYTIC METHOD; ARTICLE; BRAIN TISSUE; COMPARATIVE STUDY; DERIVATIZATION; GAS CHROMATOGRAPHY; HUMAN; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ANIMAL; BRAIN; BRAIN LEVEL; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLISM; PROCEDURES;

ANIMALS; ARACHIDONIC ACIDS; BRAIN; BRAIN CHEMISTRY; CHROMATOGRAPHY, LIQUID; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MASS SPECTROMETRY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

EID: 84903541666     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2014.03.007     Document Type: Article

References (97)

1. Cowley T., Fahey B., O'Mara S. Eur. J. Neurosci. 2008, 27:2999-3008.
2. Cazevieille C., Muller A., Meynier F., Dutrait N., Bonne C. Neurochem. Int. 1994, 24:395-398.
3. Adibhatla R.M., Hatcher J.F. Role of Lipids in Brain Injury and Diseases 2007.
4. Calder P.C. Biochimie 2009, 91:791-795.
5. Wymann M.P., Schneiter R. Nat. Rev. Mol. Cell Biol. 2008, 9:162-176.
6. Schmitz G., Ecker J. Prog. Lipid Res. 2008, 47:147-155.
7. Buczynski M.W., Dumlao D.S., Dennis E.A. J. Lipid Res. 2009, 50:1015-1038.
8. Taketo M.M. J. Natl. Cancer Inst. 1998, 90:1529-1536.
9. Shaftel S.S., Olschowka J.A., Hurley S.D., Moore A.H., O'Banion M.K. Mol. Brain Res. 2003, 119:213-215.
10. Wilson N.H. Chapter 7: Synthetic Eicosanoids. The Eicosanoids 2004, 69-94.
11. Gierse J.K., McDonald J.J., Hauser S.D., Rangwala S.H., Koboldt C.M., Seibert K. J. Biol. Chem. 1996, 271:15810-15814.
12. Vane J., Bakhle Y., Botting R. Annu. Rev. Pharmacol. Toxicol. 1998, 38:97-120.
13. Joo M., Sadikot R.T. Mediators Inflamm. 2012, 1-6.
14. Liang X., Wu L., Hand T., Andreasson K. J. Neurochem. 2005, 92:477-486.
15. Alix E., Schmitt C., Strazielle N., Ghersi-Egea J.-F., Prostaglandin E. Cerebrospinal Fluid Res. 2008, 5:5.
16. Ricciotti E., FitzGerald G.A. Arterioscler. Thromb. Vasc. Biol. 2011, 31:986-1000.
17. Samuelsson B., Dahlen S.E., Lindgren J.A., Rouzer C.A., Serhan C.N. Science 1987, 237:1171-1176.
18. Mahipal S.V., Subhashini J., Reddy M.C., Reddy M.M., Anilkumar K., Roy K.R., Reddy G.V., Reddanna P. Biochem. Pharmacol. 2007, 74:202-214.
19. Schweiger D., Fürstenberger G., Krieg P. J. Lipid Res. 2007, 48:553-564.
20. Wang M.-L., Huang X.-J., Fang S.-H., Yuan Y.-M., Zhang W.-P., Lu Y.-B., Ding Q., Wei E.-Q. Biochem. Biophys. Res. Commun. 2006, 350:399-404.
21. Ciceri P., Rabuffetti M., Monopoli A., Nicosia S. Br. J. Pharmacol. 2001, 133:1323-1329.
22. Namura Y., Shio H., Kimura J. Brain Edema 1994, IX:296-299. Springer.
23. Fonteh A.N., Harrington R.J., Huhmer A.F., Biringer R.G., Riggins J.N., Harrington M.G. Dis. Markers 2006, 22:39-64.
24. Spector A.A., Fang X., Snyder G.D., Weintraub N.L. Prog. Lipid Res. 2004, 43:55-90.
25. Newman J.W., Morisseau C., Hammock B.D. Prog. Lipid Res. 2005, 44:1-51.
26. Alkayed N.J., Birks E.K., Hudetz A.G., Roman R.J., Henderson L., Harder D.R. Am. J. Physiol. Heart Circ. Physiol. 1996, 271:H1541-H1546.
27. Zhang W., Otsuka T., Sugo N., Ardeshiri A., Alhadid Y.K., Iliff J.J., DeBarber A.E., Koop D.R., Alkayed N.J. Stroke 2008, 39:2073-2078.
28. Yokota K., Tonai T., Horie K., Shono F., Yamamoto S. Adv. Prostaglandin Thromboxane Leukotriene Res. 1985, 15:33.
29. Schweer H., Watzer B., Seyberth H.W. J. Chromatogr. B: Biomed. Sci. Appl. 1994, 652:221-227.
30. Blewett A.J., Varma D., Gilles T., Libonati J.R., Jansen S.A. J. Pharm. Biomed. Anal. 2008, 46:653-662.
31. Masoodi M., Nicolaou A. Rapid Commun. Mass Spectrom. 2006, 20:3023-3029.
32. Liang Y., Wei P., Duke R.W., Reaven P.D., Harman S.M., Cutler R.G., Heward C.B. Free Radic. Biol. Med. 2003, 34:409-418.
33. Yue H., Strauss K.I., Borenstein M.R., Barbe M.F., Rossi L.J., Jansen S.A. J. Chromatogr. B 2004, 803:267-277.
34. Powell W.S. Eicosanoid Protocols 1999, 11-24. Springer.
35. Folch J., Lees M., Sloane-Stanley G. J. Biol. Chem. 1957, 226:497-509.
36. Bligh E., Dyer W.J. Can. J. Biochem. Physiol. 1959, 37:911-917.
37. Saunders R.D., Horrocks L.A. Anal. Biochem. 1984, 143:71-75.
38. Lee S.H., Williams M.V., DuBois R.N., Blair I.A. Rapid Commun. Mass Spectrom. 2003, 17:2168-2176.
39. Golovko M.Y., Murphy E.J. J. Lipid Res. 2008, 49:893-902.
40. Stenson W.F. Curr. Protoc. Immunol. 2001, 7-33. 7.33. 31-37.33. 16.
41. O'Donnell V.B., Maskrey B., Taylor G.W. Lipid Signaling Protocols 2009, 1-19. Springer.
42. Brose S.A., Baker A.G., Golovko M.Y. Lipids 2013, 48:1-9.
43. Yue H., Jansen S.A., Strauss K.I., Borenstein M.R., Barbe M.F., Rossi L.J., Murphy E. J. Pharm. Biomed. Anal. 2007, 43:1122-1134.
44. Yasaka Y., Tanaka M., Shono T., Tetsumi T., Katakawa J.I. J. Chromatogr. A 1990, 133-140. 508.
45. Dumlao D.S., Buczynski M.W., Norris P.C., Harkewicz R., Dennis E.A. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 2011, 1811:724-736.
46. Yergey J.A., Kim H.Y., Salem N. Anal. Chem. 1986, 58:1344-1348.
47. Kingsley P.J., Rouzer C.A., Saleh S., Marnett L.J. Anal. Biochem. 2005, 343:203-211.
48. Kingsley P.J., Marnett L.J. Methods Enzymol. 2007, 433:91-112.
49. Brose S.A., Thuen B.T., Golovko M.Y. J. Lipid Res. 2011, 52:850-859.
50. Tajima Y., Ishikawa M., Maekawa K., Murayama M., Senoo Y., Nishimaki-Mogami T., Nakanishi H., Ikeda K., Arita M., Taguchi R. Lipids Health Dis. 2013, 12:68.
51. Axelsen P.H., Murphy R.C. J. Lipid Res. 2010, 51:660-671.
52. Miller T.M., Donnelly M.K., Crago E.A., Roman D.M., Sherwood P.R., Horowitz M.B., Poloyac S.M. J. Chromatogr. B 2009, 877:3991-4000.
53. Obata T., Nagakura T., Maeda H., Yamashita K., Maekawa K. J. Chromatogr. B: Biomed. Sci. Appl. 1999, 731:73-81.
54. Masoodi M., Mir A.A., Petasis N.A., Serhan C.N., Nicolaou A. Rapid Commun. Mass Spectrom. 2008, 22:75-83.
55. Xu S., Zheng S., Shen X., Yao Z., Pivnichny J., Tong X. J. Pharm. Biomed. Anal. 2007, 44:581-585.
56. Urban M., Enot D.P., Dallmann G., Körner L., Forcher V., Enoh P., Koal T., Keller M., Deigner H.-P. Anal. Biochem. 2010, 406:124-131.
57. A.A. Mir, University of Bradford, 2009. The effect of eicosapentaenoic acid on brain and platelet produced bioactive lipid mediators: the effect of eicosapentaenoic acid, docosapentaenoic acid and other polyunsaturated fatty acids on the eicosanoids and endocannabinoids produced by rat brain and human platelets using electrospray ionisation tandem mass spectrometry-based analysis.
58. Ogorochi T., Narumiya S., Mizuno N., Yamashita K., Miyazaki H., Hayaishi O. J. Neurochem. 1984, 43:71-82.
59. Basselin M., Fox M.A., Chang L., Bell J.M., Greenstein D., Chen M., Murphy D.L., Rapoport S.I. Neuropsychopharmacology 2009, 34:1695-1709.
60. Basselin M., Ramadan E., Igarashi M., Chang L., Chen M., Kraft A.D., Harry G.J., Rapoport S.I. J. Cereb. Blood Flow Metab. 2010, 31:486-493.
61. Maskrey B.H., O'Donnell V.B. Biochem. Soc. Trans. 2008, 36:1055-1059.
62. Strauss K.I., Gruzdev A., Zeldin D.C. Prostaglandins & Other Lipid Mediators 2012.
63. Modi H.R., Taha A.Y., Kim H.W., Chang L., Rapoport S.I., Cheon Y. J. Neurochem. 2013, 124:376-387.
64. Cheon Y., Park J.Y., Modi H.R., Kim H.W., Lee H.J., Chang L., Rao J.S., Rapoport S.I. J. Neurochem. 2011, 119:364-376.
65. Igarashi M., Kim H.-W., Gao F., Chang L., Ma K., Rapoport S.I. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 2012, 1821:1235-1243.
66. Farias S.E., Basselin M., Chang L., Heidenreich K.A., Rapoport S.I., Murphy R.C. J. Lipid Res. 2008, 49:1990-2000.
67. Ecker J. J. Sep. Sci. 2012, 35:1227-1235.
68. Yoshida Y., Kodai S., Takemura S., Minamiyama Y., Niki E. Anal. Biochem. 2008, 379:105-115.
69. Newman J.W., Watanabe T., Hammock B.D. J. Lipid Res. 2002, 43:1563-1578.
70. Liu H., Li W., Ahmad M., Rose M.E., Miller T.M., Yu M., Chen J., Pascoe J.L., Poloyac S.M., Hickey R.W. Neurotox. Res. 2013, 24:191-204.
71. Majors R.E. LG-GC North Am. 2007.
72. Birkle D.L., Bazan H.E., Bazan N.G. Lipids and Related Compounds 1989, 227-244. Springer.
73. Qu W., Bradbury J.A., Tsao C.-C., Maronpot R., Harry G.J., Parker C.E., Davis L.S., Breyer M.D., Waalkes M.P., Falck J.R. J. Biol. Chem. 2001, 276:25467-25479.
74. Lee S.H., Williams M.V., DuBois R.N., Blair I.A. Rapid. Commun. Mass Spectrom. 2003, 17:2168-2176.
75. Amruthesh S.C., Falck J., Ellis E.F. J. Neurochem. 1992, 58:503-510.
76. Tsikas D. J. Chromatogr. B: Biomed. Sci. Appl. 1998, 717:201-245.
77. Yang S., Ma Y., Liu Y., Que H., Zhu C., Liu S. J. Neurotrauma 2012, 29:2696-2705.
78. Curtis-Prior P.B. The Eicosanoids 2004, Wiley Online Library.
79. Wiswedel I., Hirsch D., Nourooz-Zadeh J., Flechsig A., Lück-Lambrecht A., Augustin W. Free Radic. Res. 2002, 36:1-11.
80. Nithipatikom K., DiCamelli R.F., Kohler S., Gumina R.J., Falck J.R., Campbell W.B., Gross G.J. Anal. Biochem. 2001, 292:115-124.
81. Milatovic D., Aschner M. Curr. Protoc. Toxicol. 2009, 12-14.
82. Neverova I., Van Eyk J.E. J. Chromatogr. B 2005, 815:51-63.
83. Mesaros C., Lee S.H., Blair I.A. J. Chromatogr. B 2009, 877:2736-2745.
84. Rosenberger T.A., Villacreses N.E., Hovda J.T., Bosetti F., Weerasinghe G., Wine R.N., Harry G.J., Rapoport S.I. J. Neurochem. 2004, 88:1168-1178.
85. Saenger A.K., Laha T.J., Edenfield M.J., Sadrzadeh S.M. Clin. Biochem. 2007, 40:1297-1304.
86. Margalit A., Duffin K.L., Isakson P.C. Anal. Biochem. 1996, 235:73-81.
87. Winnik W.M., Kitchin K.T. Toxicol. Appl. Pharmacol. 2008, 233:100-106.
88. Foltz R.L., Edom R.W. J. Mass Spectrom. Soc. Jpn. 1998, 46:235-239.
89. Abdel-Halim M.S., Holst H., Meyerson B., Sachs C., Änggård E. J. Neurochem. 1980, 34:1331-1333.
90. Kadiiska M., Gladen B., Baird D., Germolec D., Graham L., Parker C., Nyska A., Wachsman J., Ames B., Basu S. Free Radic. Biol. Med. 2005, 38:698-710.
91. Paglia G., Magnúsdóttir M., Thorlacius S. J. Chromatogr. B 2012, 898:111-120.
92. Kortz L., Helmschrodt C., Ceglarek U. Anal. Bioanal. Chem. 2011, 399:2635-2644.
93. Reis A., Rudnitskaya A., Blackburn G.J., Fauzi N.M., Pitt A.R., Spickett C.M. J. Lipid Res. 2013, 54:1812-1824.
94. Abdel-Halim M., Sjöquist B., Änggård E. Acta Pharmacol. Toxicol. 1978, 43:266-272.
95. Anton R.F., Wallis C., Randall C.L. Prostaglandins 1983, 26:421-429.
96. Bosisio E., Galli C., Galli G., Nicosia S., Spagnuolo C., Tosi L. Prostaglandins 1976, 11:773-781.
97. A. Ford-Hutchinson, in: Federation proceedings, 1985, pp. 25.